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Abstract
Introduction: Meta- analytic reviews suggest similar outcomes across trauma- 
focused psychotherapies for adults with post- traumatic stress disorder (PTSD). 
However, this conclusion may be premature due to suboptimal statistical- review 
methodologies. Network meta- analysis (NMA) allows a detailed rank- ordering 
of the efficacy of established psychotherapy interventions derived from indirect 
evidence as well as results from direct head- to- head comparisons.
Objective: We sought to determine the efficacy and attrition rates of psycho-
therapy interventions for PTSD by applying NMA.
Methods: We searched EMBASE, PsychINFO, PTSDPubs and PubMed for ran-
domised controlled trials that compared psychotherapies either head- to- head or 
against controls for adults with PTSD. A frequentist NMA was used to compare 
direct and indirect effects to determine the efficacy and attrition rates of psycho-
therapy interventions.
Results: Of the 5649 papers identified, 82 trials comprising of 5838 patients were 
included. The network comprised 17 psychotherapies and four control conditions. 
Network estimates indicated superior efficacy of meta- cognitive therapy and cog-
nitive processing therapy over other psychotherapies (ESs between = 0.26 and 
2.32). Written exposure therapy and narrative exposure therapy were associated 
with lower risk of drop out when considered alongside other psychotherapies. 
Confidence in the network meta- analytic estimates was considered moderate for 
both outcomes.
Conclusions: In broad terms, therapeutic commensurability was evident. 
Nevertheless, with additional studies and larger sample sizes, meta- cognitive and 
written exposure therapies could indeed differentiate themselves from other ap-
proaches as having favourable efficacy and acceptability respectively. These find-
ings may inform clinical decision- making, as well as guide future research for 
PTSD.
K E Y W O R D S
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1  |  INTRODUCTION
Post- traumatic stress disorder (PTSD) is characterised 
by exposure to trauma and symptom clusters includ-
ing re- experiencing of the traumatic event, avoidance of 
stimuli associated with the trauma, negative alterations 
in cognition and mood, and hyperarousal.1 It is common 
(8.3% lifetime prevalence2) and associated with multiple 
negative outcomes, including functional impairment,3 
suicidality,4 co- occurring psychological disorders5,6 and 
physical morbidity.7,8
There is an apparent consensus within the PTSD field 
that trauma- focused psychotherapies are, for the most 
part, comparable so far as efficacy and adherence are 
concerned.9- 11 In some respects, this is surprising. Even 
though all trauma- focused psychotherapies are thought to 
involve a meaningful processing of the trauma memory 
in some respect, the proposed underlying mechanisms of 
trauma- focussed approaches, and indeed, the specific ap-
proaches of each respective intervention nonetheless vary. 
Comparable efficacy and adherence of trauma- focused 
psychotherapies have been supported by meta- analytic 
reviews that consistently suggest that cognitive behaviour 
therapy (CBT), exposure therapies and eye movement de-
sensitisation and reprocessing (EMDR) are similarly effec-
tive in treating PTSD.9,11- 14 A meta- analysis by Ourgin14 
found no difference between cognitive therapy (CT) and 
exposure therapy; however, findings were analysed from 
only five studies. A Cochrane review15 reported no statis-
tically significant differences between trauma focussed- 
cognitive behaviour therapy (TF- CBT), EMDR and Stress 
Management post- treatment. Further, the authors re-
ported that TF- CBT, EMDR and CBT were more effective 
than other therapies (ie non- directive, supportive, person- 
centred counselling, hypnotherapy and psychodynamic 
therapy). A comprehensive meta- analysis by Watts et al.11 
reported effect sizes indicating superior efficacy for cogni-
tive processing therapy (CPT; g = 1.69), exposure and CT 
(g = 1.52) and prolonged exposure (PE; g = 1.38).
The above reviews have informed the development of 
treatment guidelines and most guidelines recommend TF- 
CBTs. These are considered to include CT, CPT and PE 
therapy, as well as EMDR.16- 19
However, the evidence base has been built upon studies 
which have rarely included more than two treatment arms 
and meta- analytic methodologies have not, until recently, 
been able to incorporate indirect evidence across studies 
which compare different combinations of approaches. For 
instance, the above- mentioned reviews of Bisson et al.15 
and Watts et al.11 relied on evidence derived only from a se-
ries of separate head- to- head comparisons, limiting their 
findings. Therefore, the assumption of equality of out-
comes across trauma- focused psychotherapies may have 
been prematurely conferred. In contrast, a full account 
of the evidence base would additionally consider indirect 
evidence, whereby the superiority of a given intervention 
can be ascertained even in instances where direct head- to- 
head comparison studies have not been conducted.
Network meta- analysis (NMA) holds particular prom-
ise when considering the relative efficacy of a broad range 
of psychotherapies. The approach provides a statistical 
methodology for evidence synthesis that can integrate 
both direct and indirect evidence from multiple treatment 
comparisons to estimate the inter- relationships across 
treatments.20 The NMA approach may be particularly use-
ful when synthesising a clinical literature characterised 
by a broad array of different therapeutic modalities and 
‘brands’ which have not always been directly compared— 
such as PTSD.
To date, there have been three NMAs exploring psy-
chotherapeutic efficacies for adults diagnosed with PTSD. 
However, a significant limitation of each of these has been 
the lumping of multiple separate psychotherapies into TF- 
CBT or ‘psychotherapy’ clusters, thus calling for a NMA 
whereby the relative efficacy and adherence of individual 
psychotherapies can be ascertained. For instance, Gerger 
et al.10 synthesised data from 66 randomised controlled 
trials (RCTs) and reported no superior interventions, with 
similar efficacy reported for CBT, CT, EMDR and exposure 
therapy. However, this NMA did not define a distinction 
between CBT, exposure therapies, or CT and included 
these all within a TF- CBT framework for the final NMA 
model, reducing the granularity and clinical utility of 
Summations
• Our network meta- analysis did not identify 
highly divergent levels of efficacy and accept-
ability among psychotherapies.
• Meta- cognitive therapy and cognitive process-
ing therapy were nonetheless the most effica-
cious of the included psychotherapies.
• Narrative exposure therapy and written expo-
sure therapy had relatively high rates of treat-
ment completion when considered alongside 
other psychotherapies.
Limitations
• We included psychotherapy approaches which 
have been subject to few trials and which 
await replication efforts from independent 
investigators.
• Our review was limited to individual face- to- 
face psychotherapies.
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these results. Finally, publications were restricted to 1980 
until 2010, such that recent RCTs were not included.
The second NMA by Merz, Schwarzer and Gerger21 ex-
amined the efficacy and acceptability of psychotherapies, 
pharmacotherapies or combined treatment approaches, at 
post- treatment and long- term follow- up. In this context, 
acceptability referred to the proportion of participants 
completing treatment rather than dropping out due to ad-
verse effects of the intervention. Their results indicated a 
superiority of psychotherapies over pharmacotherapy at 
long- term follow- up, and no differences in acceptability 
across comparisons. This study utilised data from only 12 
RCTs, with long- term follow- up not reported for the full 
sample (six studies only). Most importantly, however, the 
findings do not allow a comparison of the relative efficacy 
of each individual psychotherapy, as each approach was 
analysed under the broad umbrella of ‘psychotherapy’. 
Thus, CBT, PE, EMDR and Seeking Safety (a CBT- and 
psychodynamic- derived group therapy for PTSD and 
co- morbid substance use that proscribes exploration of 
trauma memories22) were analysed as a unitary interven-
tion category, precluding an assessment of psychothera-
peutic (non)similarity.
A third NMA was recently reported by Mavranezouli 
and colleagues.23 These authors delineated EMDR from 
TF- CBT, but did not distinguish between individual TF- 
CBTs, such as CPT and exposure- based interventions. 
Also, Mavranezouli et al.23 did not consider acceptabil-
ity in their analyses. Acceptability would appear to be 
a vital outcome to understand with regard to the non- 
distinctiveness of TF- CBTs, given that the common con-
cern that exposure- based approaches may be associated 
with high rates of treatment dropout and discontinuation.
The large number of meta- analytic reviews has missed 
an opportunity to truly integrate the sizable body of PTSD 
psychotherapeutic literature and to examine whether some 
therapies are indeed more efficacious and acceptable than 
others. The NMA approach holds great promise for iden-
tifying the most efficacious and acceptable interventions 
for PTSD; however, the application of NMA has likewise, 
until now, overlooked the opportunity to identify whether 
some TF- CBTs are more efficacious and acceptable than 
others. Therefore, in this study, the aim was to conduct 
a comprehensive systematic review and NMA to inform 
clinical practice by comparing psychotherapies to evaluate 
their efficacy on PTSD symptom reduction, as well as their 
acceptability defined as all- cause discontinuation.24
2  |  METHOD
The review was registered with the International pro-
spective register of systematic reviews (PROSPERO 
CRD42019119814), and we report the results consistent 
with the PRISMA extensions statement for NMA.25
2.1 | Search strategy and 
selection criteria
A comprehensive and systematic literature search was 
conducted to determine studies for inclusion for the 
NMA. The databases of EMBASE, PsychINFO, PTSDPubs 
and PubMed were searched from their inception to 21 
January 2020. Search terms included MeSH terms as well 
as search terms such as “post- traumatic stress disorder” 
AND “psychotherapy” AND “ramdomi?ed controlled 
trial”. See Supplementary Material S1 for specific search 
term strategies. The principal investigator (BJ) and sec-
ond author (AL) independently screened all titles and 
abstracts of studies identified by the electronic search. 
The full texts of any study deemed potentially eligible 
(n = 220) were then also independently screened by in-
vestigators BJ and AL, and disagreement was resolved 
by discussion. See Supplementary Material S2 for the ex-
cluded trials.
We included RCTs comparing bona- fide psychother-
apies to control (ie waitlist), or another psychotherapy, 
for the treatment of adults (≥18  years old and of both 
sexes), with a primary diagnosis of PTSD according to 
the standard operationalised diagnostic criteria in the 
Diagnostic and Statistical Manual of Mental Disorders 
(DSM- III- R26; DSM- IV- TR27; DSM- IV28; and DSM- 529) 
and the International Classification of Diseases and re-
lated health problems (ICD- 930; ICD- 1031). Studies de-
rived from DSM- III1 criteria were not included due to 
significant changes to the PTSD diagnostic criteria from 
DSM- III1 to DSM- III- R,26 as well as publication date, 
which may have violated the transitivity assumption. 
Two studies were excluded for this, and other reasons 
(see Supplementary Material S2 for further details). 
Papers were required to be in English and published 
in a peer- reviewed journal. In contrast to the stated 
PROSPERO registration (CRD42019119814), we did not 
require adherence of primary studies to the CONSORT 
statement as we were not always able to reliably deter-
mine whether this was the case. So far as the description 
of therapies is concerned, at least two of the following 
had to be fulfilled for study inclusion: (a) a citation to 
an established school or approach to psychotherapy, 
(b) a description of the therapy that contained a refer-
ence to a psychological process (eg operant condition-
ing), (c) a reference to a treatment manual that was used 
to guide the delivery of the treatment and/or (d) the 
identification of active ingredients. See Supplementary 
Material S1 for definition and description of bona- fide 
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psychotherapies. We considered only individual, face- 
to- face psychotherapies (eg excluding group or conjoint 
interventions) to improve methodological rigour and to 
help inform practitioners working with individuals in 
routine treatment settings, where trauma- focused ther-
apies involving the processing of idiosyncratic trauma 
memories are typically administered in an individual 
therapy context. Additionally, we only included stud-
ies which reported a direct comparison between at least 
two individual psychotherapy modalities, or between a 
psychotherapy and control condition, and we thus ex-
cluded studies of sequential treatments if direct com-
parison data between individual interventions could not 
be extracted. A variety of active and waitlist conditions 
have been utilised in the literature. The control condi-
tions were combined into four separate nodes (waitlist, 
active supportive therapy, treatment- as- usual and psy-
choeducation). Supplementary Material S1 highlights 
the key features of each unique control condition which 
informed the categorisation process.
2.2 | Outcomes
The primary outcome was efficacy, represented by PTSD 
symptomatic change from baseline to post- treatment on 
a validated scale for PTSD. Long- term follow- up was out-
side the scope of the project. When PTSD symptoms were 
measured with more than one validated rating scale, a pre-
defined hierarchy based on psychometric properties and 
consistency of use across included trials was utilised (see 
Supplementary Material S1). More frequently used scales 
and self- rated PTSD symptoms were preferred. Self- rated 
scales were favoured over interview- based measures given 
that proportionately few studies administered interview- 
based measures at post- treatment and because self- report 
measures do not have the addition of interviewer- based 
variance beyond respondent- based variance alone. Results 
from intention- to- treat (ITT) analyses were preferred over 
results from completer analyses. Between- group post- 
treatment standardised mean differences (SMD) with 95% 
confidence intervals (95% CIs) were calculated, with an 
effect of 0.24 to imply clinical importance.32
A secondary outcome was acceptability. Consistent 
with previous network meta- analytic reviews,21,24,33 ac-
ceptability refers to treatment discontinuation calculated 
by the proportion of patients who withdrew for any rea-
son. Favourable acceptability reflects the completion of 
therapy or absence of discontinuation, and encompasses 
the notions of treatment adherence and non- attrition. 
Odds ratios (OR) with 95% CIs were used as a measure of 
the association between the psychotherapeutic approach 
and acceptability.
2.3 | Data extraction
Data were extracted from the included studies by BJ using 
a structured form. Sample sizes, baseline and end of treat-
ment means, and standard deviations (SDs) were extracted 
for effect size calculation for each treatment group. Where 
CIs were reported, conversions to SDs were calculated 
according to formulas provided by Higgins and Green.34 
Authors of 22 studies were contacted due to insufficient 
data reported in the primary paper, with authors of four 
studies providing the relevant information.35- 38 In addi-
tion to the data required for effect size calculation, other 
characteristics of trials were also extracted to identify po-
tential effect modifiers, these being index trauma type (eg 
interpersonal violence), year of publication and diagnostic 
criteria.
2.4 | Risk of Bias
The Cochrane Risk of Bias assessment tool was used to 
assess the quality of included studies.39 The assessment of 
the risk of bias included a brief training period whereby 
BJ and a co- rater reached consensus with a random sam-
ple of selected studies (n = 10), with the remainder being 
assessed by BJ. In addition, the Confidence in Network 
Meta- Analysis (CINeMA) platform was used to evaluate 
the quality of studies across the network.40,41
2.5 | Review of the network geometry
Published RCTs including patients with PTSD were ana-
lysed. In the network, each psychotherapy is indicated by 
a node, and comparisons between psychotherapies are 
shown by the links between the nodes.
2.6 | Data analysis
For the primary analyses, SMD were estimated for con-
tinuous efficacy outcomes and ORs for dichotomous attri-
tion outcomes using pairwise comparisons and NMA. The 
study effect sizes were then synthesised using a random- 
effects NMA model. Frequentist network meta- analyses 
were conducted using CINeMA, which integrates the R 
netmeta package.40 In the NMA, the heterogeneity vari-
ance parameter was assumed to be the same for all treat-
ment comparisons. Heterogeneity was considered low 
with a value of τ2 = 0.04, moderate as τ2 = 0.09 and high 
heterogeneity as τ2 = 0.16.42
Consistency, that is, the agreement between direct and 
indirect evidence was statistically evaluated using a global 
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design- by- treatment interaction model,43 and locally, by 
separating direct evidence from indirect evidence.44 The 
transitivity assumption was further evaluated by compar-
ing the distribution of methodological variables that could 
act as effect modifiers across treatment comparisons in a 
pairwise meta- regression. A Knapp- Hartung method of 
meta- regression was conducted with separate estimates 
of τ2 for each subgroup.42 Estimates of τ2 were calculated 
using the maximum likelihood method.42 Waitlist was 
utilised as the standard comparator due to the condition 
being the most commonly compared control (n treatment 
arms = 57). To rank the treatment, each therapy was plot-
ted for each NMA estimate variable compared to wait-
list.44 To determine whether the network was susceptible 
to small- study bias, a funnel plot comparing studies with 
waitlist was produced, with asymmetry assed with the 
Egger's regression test.45
3  |  RESULTS
3.1 | Results of the search
Results of the systematic search identified 5649 citations. 
Independent screening of titles and abstracts yielded 
high agreement between raters (Cohen's Kappa  =  .94; 
99.32% agreement), resulting in 220 eligible articles re-
trieved in full- text (see Figure  1 for PRISMA diagram). 
Screening full- text articles yielded high inter- rater reli-
ability (Cohen's Kappa = .95; 97.73% agreement). Overall, 
82 RCTs were included in the analysis, comprising 5775 
participants (see Supplementary Material S1 for full refer-
ence list). The included studies were conducted between 
1991 and 2020, comparing 17 psychotherapies and four 
control conditions.
3.2 | Description of studies
The ITT outcomes were reported in 66% of the studies. 
The mean treatment arm size was 34.40 participants (me-
dian = 28, SD = 28.22). In total, 3543 participants were 
randomly assigned to an active psychotherapy, with 2295 
randomly assigned to a control (eg waitlist, active sup-
portive therapy, TAU or psychoeducation). See Table 1 for 
characteristics of included studies.
A number of included studies were based upon small 
sample sizes, and some network nodes were comprised 
of relatively few studies. We nonetheless included these 
studies in our review on the basis that they may be infor-
mative so far as the potential value of new and emerging 
therapy modalities are concerned. A more refined ‘sensi-
tivity analysis’ excluding network nodes comprised of less 
than three studies and studies with fewer than 18 partici-
pants in either arm is provided in Supplementary Material 
S2 for the interested reader.
3.3 | Description of network geometry
Figure  2  shows the network of eligible comparisons for 
PTSD psychotherapies. All therapies, except psychody-
namic therapy (PDT) and dialogical exposure therapy 
(DET), had at least one non- active control comparison. 
Waitlist was the most compared control condition, being 
compared to 15 psychotherapies and control conditions. 
Three psychotherapies (DET, PDT and Skills training in 
affective and interpersonal regulation followed by expo-
sure [STAIR- PE]) were connected via a single condition 
comparison. The network was relatively well- connected, 
with the evidence set comprising 52 of the possible 210 
comparisons
Only STAIR- PE was not directly compared with at 
least one other active therapy in the network. The gold- 
standard treatments were adequately connected with 
CBT, CPT, EMDR and PE being directly compared to six, 
six, seven and 14 conditions, respectively.
3.4 | Treatment efficacy
Network and direct estimates are displayed in Table 2. The 
τ2 estimate of 0.31 suggested high between- study hetero-
geneity for the NMA.42 For network estimates, meta- CT 
(MCT) performed significantly better than CBT, EMDR, 
NET, PDT, VRET and all control conditions. CPT also per-
formed significantly better than all control comparisons, 
as well as CBT and VRET. PE performed significantly 
more favourably than CBT and control conditions, with 
the exception of Psychoeducation. PDT and STAIR- PE 
were therapies with no significant comparisons to any 
other therapy or control condition.
Head- to- head studies were also synthesised sepa-
rately to identify treatment differences, displayed above 
the diagonal in Table  2. Direct comparisons indicate 
significant treatment efficacy compared to waitlist for 
CBT, CPT, CT, EMDR, MCT, NET, PE, SIT and WET. 
Further, PE effects were significantly greater than ac-
tive supportive therapy (ACTST). Finally, PE was also 
significantly greater than TAU, as was CPT significantly 
greater than ACTST; however, significant inconsistency 
between NMA estimate and direct effects were detected 
between this comparison. The global test of inconsis-
tency based on the random- effects design- by- treatment 
interaction model was not significant, χ2 (43) = 20.72, 
p = 1.00.
6 |   JERICHO et al.
A forest plot displaying all network meta- analytic es-
timates compared to waitlist can be seen in Figure 3. For 
forest plots comparing active treatments compared to 
CBT, CPT, EMDR and PE, see Supplementary Material S2.
3.5 | Treatment acceptability
Network and direct estimates for treatment acceptability 
are displayed in Table 3. The τ2 estimate of 0.06 suggested 
F I G U R E  1  PRISMA diagram of study selection flow

























Records screened on basis of 
title and abstract (n =  4,103)
Full-text articles excluded (n = 138):
- treatment(s) did not fulfil bona-fide criteria (n = 
2)
- component or dismantling study design (n = 3)
- secondary or follow-up analyses (n = 34)
- <100% adults and/or PTSD diagnosis (n = 35)
- treatment(s) outside of scope of this review 
(e.g., group) (n = 28)
- statistical reasons (n =  3)
- not a completed RCT, peer-reviewed, published 
journal article (n = 8)
- unmet request from authors contacted for 
additional data (n = 22)
- DSM-III diagnosis (n = 2)
- Did not include a validated measure of PTSD 
symptoms (n = 1)





Studies included in quantitative 
synthesis (n = 82)
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low between- study heterogeneity for the NMA.42 Network 
estimates show NET had significantly fewer dropouts 
compared to ACTST, CPT, DET, PE, PE- SIT, PSYED and 
VRET. WET had significantly fewer dropouts compared 
to ACTST, CPT, CT, DET, EMDR, PE, PE- SIT, PSYED, 
SIT, STAIR- PE and VRET. WL produced fewer dropouts 
only compared to CPT, PE and VRET. PE had significantly 
higher dropout rates than ACTST, BET, CBT, EMDR, IPT, 
TARGET and TAU. VRET also had significantly higher 
dropout rates than ACTST, BET, CBT, EMDR, IPT, PDT, 
TARGET and TAU. MCT was the only therapy with no sig-
nificant comparisons to either active treatments or control 
conditions.
Head- to- head studies were also synthesised separately 
to assess for acceptability, displayed in the upper section 
of Table 3. Direct comparisons indicate significant treat-
ment acceptability of ACTST over PE, WET over CPT, and 
WL over CPT, PE and VRET.
Finally, splitting indirect from direct evidence43 also 
highlighted significant inconsistency between the follow-
ing non- significant comparisons: ACTST versus NET, PE 
versus EMDR, WL versus EMDR and SIT versus NET. The 
global test of inconsistency based on the random- effects 
design- by- treatment interaction model was also signifi-
cant, χ2 (42) = 61.63, p = 0.03.
3.6 | Ranking of outcomes
Table 4 presents the ranking of treatments and control con-
ditions on efficacy and acceptability compared to waitlist.46 
Three therapies (WET, IPT and EMDR) appear in the supe-
rior half of therapies for both efficacy and acceptability. VRET 
and STAIR- PE were therapies that did not fall in the superior 
half of ranks in either acceptability or efficacy. Figure 4 pre-
sents the NMA estimates for efficacy and acceptability.
3.7 | Assessment of transitivity
Subgroup analyses were conducted through a meta- 
regression to identify the impact of potential effect modifi-
ers (index trauma type, DSM edition used for diagnosis and 
year of publication). Gender was not explored as it is con-
founded by trauma type (eg samples of sexual assault sur-
vivors often 100% female and military involvement often 
100% male). The test of the model was non- significant 
(F = 0.02, df = 3, 77, p = 0.995), and the goodness- of- fit 
test was significant (τ2 = 0.46, I2 = 80.53%, Q = 395.39, 
df = 77, p < 0.001). No effect modifier was a significant 
individual covariate (index trauma type p  =  0.83; DSM 
p = 0.98; publication year p = 0.92, R2 = <0.01).
3.8 | Risk of Bias
Risk of bias (RoB) was considered low in two stud-
ies (2.40%); some concerns in 60 (73.20%); and high in 
20 (24.40%; see Figure  5). See Supplementary Material 
S1 for further discussion of the assessments per study. 
The network meta- analyses relied predominantly on 
evidence with moderate RoB with low- to- moderate in-
directness. Confidence in the network of meta- analyses 
was considered mostly moderate for efficacy and low to 
moderate for acceptability outcomes. Mixed evidence 
comparisons with low confidence within the efficacy net-
work included CBT:PDT; PE:PE- SIT; PE:SIT; PE- SIT:SIT; 
PE- SIT:WL and SIT:WL. Mixed evidence comparisons 
with low confidence within the acceptability network 
included ACTST:NET, ACTST:PSYED; ACTST:VRET, 
BET:EMDR, BET:WL, CCBT:TAU, CPT:DET, CT:PSYED, 
F I G U R E  2  The network structure for PTSD psychotherapies. 
The size of each node is proportional to the number of participants, 
and the width of the lines is proportional to the number of trials 
comparing each pair of interventions. ACTST; Active Supportive 
Therapy (control); BET, Brief Eclectic Therapy; CBT, Cognitive 
behavioural therapy; CPT, Cognitive Processing Therapy; CT, 
cognitive therapy; DET, Dialogical Exposure Therapy; EMDR, eye 
movement desensitization and reprocessing; IPT, Interpersonal 
Therapy; MCT, Metacognitive Therapy; NET, Narrative Exposure 
Therapy; PE, Prolonged Exposure; PE- SIT, Prolonged Exposure and 
Stress Inoculation Training; PSYED, Psychoeducation (control); 
PDT, Psychodynamic Therapy; SIT, Stress Inoculation Training; 
STAIR- PE, Skills training in affective and interpersonal regulation 
followed by prolonged exposure; TARGET, Trauma Affect 
Regulation: Guide for Education and Therapy; TAU, Treatment 
as usual; VRET, Virtual Reality Exposure Therapy; WET, Written 
Exposure Therapy; WL, Waitlist (control)
14 |   JERICHO et al.
T A B L E  2  Standardised mean differences (SMD; 95% CI) of Direct and overall Network Estimates of Efficacy



























































































































































































































































































































































































































































































































































































Note: Direct estimates are displayed above the comparison line, NMA estimates sit below. Bold = significant effect (p < 0.05) with estimates above 0 favouring 
intervention in the column, *p < 0.1; **p < 0.05 for significant inconsistency detected between direct and indirect evidence, ^ means no inconsistency 
comparison due to lack of indirect evidence.
Abbreviations: Active Supportive Therapy (control); ACTST; BET, Brief Eclectic Therapy; CBT, Cognitive behavioural therapy; CPT, Cognitive Processing 
Therapy; CT, cognitive therapy; DET, Dialogical Exposure Therapy; EMDR, eye movement desensitization and reprocessing; IPT, Interpersonal Therapy; 
MCT, Metacognitive Therapy; NET, Narrative Exposure Therapy; PDT, Psychodynamic Therapy; PE, Prolonged Exposure; PE- SIT, Prolonged Exposure and 
Stress Inoculation Training; PSYED, Psychoeducation (control); SIT, Stress Inoculation Training; STAIR- PE, Skills training in affective and interpersonal 
regulation followed by prolonged exposure; TARGET, Trauma Affect Regulation: Guide for Education and Therapy; TAU, Treatment as usual; VRET, Virtual 
Reality Exposure Therapy; WET, Written Exposure Therapy; WL, Waitlist (control).
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Note: Direct estimates are displayed above the comparison line, NMA estimates sit below. Bold = significant effect (p < 0.05) with estimates above 0 favouring 
intervention in the column, *p < 0.1; **p < 0.05 for significant inconsistency detected between direct and indirect evidence, ^ means no inconsistency 
comparison due to lack of indirect evidence.
Abbreviations: Active Supportive Therapy (control); ACTST; BET, Brief Eclectic Therapy; CBT, Cognitive behavioural therapy; CPT, Cognitive Processing 
Therapy; CT, cognitive therapy; DET, Dialogical Exposure Therapy; EMDR, eye movement desensitization and reprocessing; IPT, Interpersonal Therapy; 
MCT, Metacognitive Therapy; NET, Narrative Exposure Therapy; PDT, Psychodynamic Therapy; PE, Prolonged Exposure; PE- SIT, Prolonged Exposure and 
Stress Inoculation Training; PSYED, Psychoeducation (control); SIT, Stress Inoculation Training; STAIR- PE, Skills training in affective and interpersonal 
regulation followed by prolonged exposure; TARGET, Trauma Affect Regulation: Guide for Education and Therapy; TAU, Treatment as usual; VRET, Virtual 
Reality Exposure Therapy; WET, Written Exposure Therapy; WL, Waitlist (control).
16 |   JERICHO et al.
EMDR:PE- SIT, EDMR:WL, NET:SIT, NET:TAU, PE:PE- 
SIT, PE:SIT, PE:VRET, PE- SIT:SIT and PE- SIT:WL. Mixed 
evidence comparisons with very low confidence within 
the acceptability network included CBT:PDT, SIT:WL and 
STAIR- PE:WL. See Supplementary Material S1 for further 
discussion of the inclusion of these outcomes in the grad-
ing of confidence in NMA.
The funnel plot in Figure  6 summarises the assess-
ment of publication bias. Examination of the 82 studies 
(where the mean of comparisons was used for multi- arm 
studies) indicated asymmetry with missing trials in the 
areas of non- significance. The Egger's test was significant 
(p < 0.001) indicating the presence of small- study bias.
3.9 | Sensitivity analysis
The results of the sensitivity analysis are reported in 
Supplementary Material S2. Table S4 of the Supplementary 
Material indicates that the rank order and magnitude of 
network estimates of efficacy and acceptability remained 
broadly similar in the more refined sample.
F I G U R E  3  Forest Plot of NMA estimates compared to waitlist. ACTST; Active Supportive Therapy (control); BET, Brief Eclectic 
Therapy; CBT, Cognitive behavioural therapy; CPT, Cognitive Processing Therapy; CT, cognitive therapy; DET, Dialogical Exposure 
Therapy; EMDR, eye movement desensitization and reprocessing; IPT, Interpersonal Therapy; MCT, Metacognitive Therapy; 
NET, Narrative Exposure Therapy; PE, Prolonged Exposure; PE- SIT, Prolonged Exposure and Stress Inoculation Training; PSYED, 
Psychoeducation (control); PDT, Psychodynamic Therapy; SIT, Stress Inoculation Training; STAIR- PE, Skills training in affective and 
interpersonal regulation followed by prolonged exposure; TARGET, Trauma Affect Regulation: Guide for Education and Therapy; TAU, 
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4  |  DISCUSSION
This NMA addressed the comparative efficacy and ac-
ceptability of PTSD psychotherapies in adults. In contrast 
to previous reviews, we analysed findings at the level of 
individual intervention types rather than under a collec-
tive banner of ‘TF- CBT’. In this respect, our findings have 
particular value for clinicians who typically apply one or 
another TF- CBT approach, such as exposure- based or CT, 
rather than a generic TF- CBT intervention. Our finding of 
differing levels of efficacy and acceptability across therapy 
modalities suggests that the tendency among researchers 
to assume apparent comparability, whether applied across 
all psychotherapies or only within trauma- focused psy-
chotherapies, may have been conferred prematurely and 
that there are differences in symptom change and dropout 
rates between different psychotherapies, and even within 
‘trauma- focused’ interventions. The effect sizes of MCT 
and CPT were approximately double that of EMDR and 
IPT, among others. Likewise, participants had approxi-
mately half the odds of discontinuing from WET and NET 
when compared to PE, MCT and CPT, among others.
Our results suggest that MCT was most efficacious; 
however, it is noted that there were high rates of incon-
sistency with sensitivity analyses, suggesting inflation of 
effect sizes. Additionally, CPT and NET were also more 
efficacious than other therapy conditions, with interper-
sonal, stress- based and exposure- adjunct therapies infe-
rior to other active therapies. While previous reviews have 
supported the relative efficacy of CPT compared to inac-
tive control conditions,47 to the best of our knowledge, 
no previous reviews have allowed consideration of the 
efficacy of MCT and CPT in the context of multiple other 
trauma- focused psychotherapies.
Our review also examined treatment acceptability. To 
the best of our knowledge, no previous review has con-
sidered treatment acceptability for PTSD from such a 
comprehensive synthesis of the psychological therapy 
literature. This is an important limitation in the extant 
literature given that efficacy and acceptability need to be 
considered hand- in- hand when considering the most ap-
propriate treatment approaches for PTSD. We found that 
written and narrative approaches reported the lowest rates 
of dropouts compared to therapeutic and control condi-
tions. Of note, PE- SIT produced significantly higher ORs 
to treatment and control conditions indicating a greater 
risk of dropout in this treatment. The results from the net-
work suggest an absence of violations of transitivity and 
the absence of statistically significant global inconsistency, 
although this is not evidence against inconsistency.48 It is 
noted there was large heterogeneity across the network for 
both outcomes, as well as suspected small- study publica-
tion bias of trials compared to waitlist.
Previous analyses of Gerger et al.10 Watts et al.11 and 
Bisson et al.9 led to speculations of therapeutic synon-
mymy. However, our findings are the first to confirm this 
assertion when comparing a large number of discrete 
therapy approaches. In contrast to Gerger et al.10 who 
condensed the literature to include five psychotherapeutic 
nodes, we included comparisons of 21 intervention arms, 
and examined a more rigorous, stringent and contem-
porary evidence base. This paper also extends the recent 
Merz21 paper of 12 RCTs, by highlighting head- to- head 
psychotherapeutic comparisons, as well as demarcating 
the efficacy between psychotherapies, rather than collaps-
ing all therapies into one comparison. While our results 
are broadly consistent with Mavranezouli et al.23 to the 
extent that EMDR and TF- CBTs were generally found to 
be better than waitlist, our findings provide additional 
insight into the relative efficacy of individual TF- CBT 
approaches, such as CPT, which was ranked more effica-
cious than a number of other TF- CBT interventions such 
as CBT, PE and CT, as well as regarding the acceptability 
of TF- CBT interventions.
The state of the literature and a number of design lim-
itations in the evaluation of psychotherapies served as 
limitations for our analyses, and in turn, the implications 
which can be drawn from our findings. First, according 
to the GRADE framework, the majority of the individual 
studies included in the review were of low and moderate 
quality. However, it is noted that the gold- standard tool uti-
lised is biased against psychotherapy, particularly with the 
inability to blind participants to their treatment condition. 
Second, the emerging status of three psychotherapies that 
have not been subjected to many RCTs necessitated in a re-
liance on head- to- head comparisons for those approaches. 
It is also acknowledged that the division between ITT and 
completer reporting in trials may have an impact on tran-
sitivity. Finally, we note that the efficacy values for some 
approaches may have been inflated by the use of waiting 
list control conditions, as waiting lists have been identified 
as a potential source of nocebo effects which could serve 
to artificially inflate estimated effect sizes.49
We also acknowledge some methodological aspects 
of our review, which also serve as limitations. At the 
review level, group formats and non- face- to- face in-
terventions were excluded to limit lack of transitivity; 
however, this resulted in the discounting of therapies 
such Mindfulness Based Stress Reduction, Dialectical 
Behaviour Therapy, telehealth and Internet- based de-
livered trials whose efficacies are acknowledged.16,19 
We also analysed only average treatment effects, with 
this methodological approach being unable to investi-
gate the potential clinical and demographic modifiers 
of treatment response, at the individual patient level. 
It is also noted that our review included many nodes, 
18 |   JERICHO et al.
increasing the risk of spurious findings. However, our 
results were broadly consistent when we conducted a 
sensitivity analysis that included fewer nodes, and the 
proportion of nodes in our analyses (47.6%) comprised 
of three or fewer individual studies was similar or less 
than other recent reviews.21,23,50 Finally, we acknowl-
edge that variations in the definition and application of 
TAU interventions may have threatened the transitivity 
of our results. However, the exclusion of studies with 
TAU arms would have resulted in the elimination of 11 
T A B L E  3  Odds Ratios (ORs; 95% CI) of direct and overall network estimates of acceptability
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Note: Direct estimates are displayed above the comparison line, NMA estimates sit below. Bold = significant effect (p<.05) with estimates above 1 favouring 
intervention in the column, *p<.1, **p<.05 for significant inconsistency detected between direct and indirect evidence, ^ means no inconsistency comparison 
due to lack of indirect evidence. ACTST; Active Supportive Therapy (control); BET, Brief Eclectic Therapy; CBT, Cognitive behavioural therapy;  CPT, Cognitive 
Processing Therapy; CT, cognitive therapy; DET, Dialogical Exposure Therapy; EMDR, eye movement desensitization and reprocessing; IPT, Interpersonal Therapy; 
MCT, Metacognitive Therapy; NET, Narrative Exposure Therapy; PE, Prolonged Exposure; PE- SIT, Prolonged Exposure and Stress Inoculation Training; PSYED, 
Psychoeducation (control); PDT, Psychodynamic Therapy; SIT, Stress Inoculation Training; STAIR- PE, Skills training in affective and interpersonal regulation 
followed by prolonged exposure; TARGET, Trauma Affect Regulation: Guide for Education and Therapy; TAU, Treatment as usual; VRET, Virtual Reality Exposure 
Therapy; WET, Written Exposure Therapy; WL, Waitlist (control).
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studies and a sample of studies disproportionately com-
prised of non- inferiority trials, so these studies were in-
cluded for reasons of literature coverage and to attain a 
representative sample of studies.
There are several suggestions for future research in light 
of the outcomes from this NMA. A particular strength of 
the network approach is that it can highlight where future 
comparisons are needed. The suboptimal connectivity il-
lustrated by the network suggests that more direct stud-
ies (ie comparisons of psychotherapies head- to- head) are 
required. It is also evident that there is little utility in the 
continued use of control conditions (ie waitlist or ACTST), 
T A B L E  3  Odds Ratios (ORs; 95% CI) of direct and overall network estimates of acceptability
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Note: Direct estimates are displayed above the comparison line, NMA estimates sit below. Bold = significant effect (p<.05) with estimates above 1 favouring 
intervention in the column, *p<.1, **p<.05 for significant inconsistency detected between direct and indirect evidence, ^ means no inconsistency comparison 
due to lack of indirect evidence. ACTST; Active Supportive Therapy (control); BET, Brief Eclectic Therapy; CBT, Cognitive behavioural therapy;  CPT, Cognitive 
Processing Therapy; CT, cognitive therapy; DET, Dialogical Exposure Therapy; EMDR, eye movement desensitization and reprocessing; IPT, Interpersonal Therapy; 
MCT, Metacognitive Therapy; NET, Narrative Exposure Therapy; PE, Prolonged Exposure; PE- SIT, Prolonged Exposure and Stress Inoculation Training; PSYED, 
Psychoeducation (control); PDT, Psychodynamic Therapy; SIT, Stress Inoculation Training; STAIR- PE, Skills training in affective and interpersonal regulation 
followed by prolonged exposure; TARGET, Trauma Affect Regulation: Guide for Education and Therapy; TAU, Treatment as usual; VRET, Virtual Reality Exposure 
Therapy; WET, Written Exposure Therapy; WL, Waitlist (control).
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given the large number of efficacious therapies available. 
New or emerging therapies need to demonstrate that they 
are as good or better than existing approaches, which 
would in turn strengthen the connectivity within the 
network of PTSD evidence. Moreover, while a consider-
ation of long- term outcomes was beyond the scope of this 
project, a NMA of long- term follow- up of PTSD studies 
would also be useful to further assess the apparent equal-
ity of outcomes assumption, as well as promoting further 
comparisons of the long- term effects of psychotherapeutic 
intervention.
As additional dismantling studies continue to ex-
plore the efficacy of active components of therapy (eg 
trauma narrative writing, breathing retraining, in vivo 
exposure and psychoeducation), a component analysis 
would help disentangle the efficacy and acceptability of 
treatment components and to examine whether differ-
ent components of psychotherapies result in comparable 
outcomes.
Our findings thus provide clarity on the PTSD psy-
chotherapy literature that, until now, has not been ex-
amined with such granularity. The integration of direct 
and indirect evidence suggests that MCT is somewhat 
more efficacious than other psychotherapies in reducing 
PTSD symptoms; however, this finding is derived from 
only two studies which included MCT, an approach 
which seemingly has not been subjected to independent 
evaluation with respect to PTSD, and high rates of in-
consistency and heterogeneity were noted with respect 
to our efficacy analyses. Written exposure and narrative 
therapies were also found to be the most tolerable and 
acceptable treatments. While the considerable heteroge-
neity and general quality of studies were poor, there was 
no evidence of violations of transitivity or overall net-
work inconsistency assumption violations. These results 
should inform future research with head- to- head, non- 
inferiority and component dismantling studies being 
recommended for further exploration and integration of 
the PTSD evidence base.
F I G U R E  4  Ranking of efficacy and acceptability outcomes. 
ACTST; Active Supportive Therapy (control); BET, Brief Eclectic 
Therapy; CBT, Cognitive behavioural therapy; CPT, Cognitive 
Processing Therapy; CT, cognitive therapy; DET, Dialogical 
Exposure Therapy; EMDR, eye movement desensitization and 
reprocessing; IPT, Interpersonal Therapy; MCT, Metacognitive 
Therapy; NET, Narrative Exposure Therapy; PE, Prolonged 
Exposure; PE- SIT, Prolonged Exposure and Stress Inoculation 
Training; PSYED, Psychoeducation (control); PDT, Psychodynamic 
Therapy; SIT, Stress Inoculation Training; STAIR- PE, Skills 
training in affective and interpersonal regulation followed by 
prolonged exposure; TARGET, Trauma Affect Regulation: Guide 
for Education and Therapy; TAU, Treatment as usual; VRET, 
Virtual Reality Exposure Therapy; WET, Written Exposure 
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